Clinical Trial Update: Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing treatment of corneal infiltrates secondary to epidemic keratoconjunctivitis has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Keratoconjunctivitis

Snippet

Sponsor: Military Hospital of Tunis | Conditions: Adenoviral Keratoconjunctivitis | Phase 4 | Status: COMPLETED